ReviewEuropean geriatric medicine2026
Scoping review on navigation interventions for older adults with cancer in Europe and beyond.
Review in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeOlder adults with cancer often experience fragmented care, multimorbidity, and psychosocial barriers that limit access to timely, coordinated services. Patient navigation (PN) provides individualized support across medical and social domains; however, evidence on models tailored to older populations in Europe is limited. This study synthesizes current evidence on PN programs for older adults with cancer in Europe and compares it with findings from other regions.
methodsA scoping review was conducted following PRISMA-ScR guidelines. PubMed, CINAHL, and Web of Science were searched (1993-2025). Data extraction included study characteristics, target populations, intervention components, navigator roles, competencies, training, evaluation, recruitment, and funding.
resultsOf 4249 records identified, 215 studies met the inclusion criteria, including 28 European PN interventions. Only two targeted adults aged ≥ 60 years, and six included participants aged 50-75 years. Compared with the United States, PN research for older adults remains less developed in Europe, while studies specifically involving adults aged ≥ 75 years are scarce worldwide. Most interventions for adults aged 50 years and older focused on patient education and barrier assessment during the screening phase and included navigator training. In this group, navigation services were mainly provided by social workers and lay navigators.
conclusionEvidence on PN for older adults with cancer in Europe remains limited but suggests potential benefits across the cancer care continuum. Given the high prevalence of multimorbidity and frailty among older adults, further research is needed to adapt patient navigation programs to the complex and individual needs of older patients with cancer.
Indexed as
Identifiers
42752854What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.